Damora Therapeutics (DMRA) PT Raised to $60 at Guggenheim

September 25, 2026 6:26 AM EDT Send to a Friend
(Updated - September 25, 2026 6:27 AM EDT)

Guggenheim raised its price target on Damora Therapeutics (NASDAQ: DMRA) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login